LISA GENTES: Open Payments
NPI 1548270945 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$209 in 12 payments from 6 companies in 2025. Trend: 2023 $254 · 2024 $270 · 2025 $209
Food & beverage: $209
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $69 |
| Novo Nordisk Inc | 3 | $61 |
| Lilly USA, LLC | 2 | $30 |
| PFIZER INC. | 1 | $19 |
| Lundbeck LLC | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: Kerendia, Rybelsus, MOUNJARO, VYNDAQEL, Ozempic, REXULTI, CAPLYTA.
Industry payments across NE — which companies pay providers there.
